| -Change in Payables and Accrued Expense |
$1.68M |
-$4.98M |
$2.00M |
-$206,000.00 |
$798,000.00 |
| Financing Cash Flow |
$463.42M |
$10.05M |
$623,000.00 |
-$368,000.00 |
$218.38M |
| Net Investment Purchase and Sale |
-$441.47M |
$42.53M |
$12.17M |
-$4.06M |
-$183.45M |
| Net PPE Purchase and Sale |
-$99,000.00 |
$0.00 |
$213,000.00 |
$1,000.00 |
-$139,000.00 |
| Net Cash Flow from Continuing Investing Activities |
-$441.57M |
$42.53M |
$12.38M |
-$4.06M |
-$183.59M |
| Net cash flow from investing |
-$441.57M |
$42.53M |
$12.38M |
-$4.06M |
-$183.59M |
| -Change in Other Current Liabilities |
-$129,000.00 |
-$97,000.00 |
-$91,000.00 |
-$90,000.00 |
-$87,000.00 |
| -Change in Prepaid Assets |
-$2.16M |
$1.65M |
-$694,000.00 |
$139,000.00 |
-$398,000.00 |
| Change in Working Capital |
-$605,000.00 |
-$3.43M |
$1.22M |
-$157,000.00 |
$313,000.00 |
| Other Non-Cash Items |
$126,000.00 |
$93,000.00 |
$92,000.00 |
$89,000.00 |
$87,000.00 |
| Depreciation & Depletion & Amortization |
$7,000.00 |
$14,000.00 |
$46,000.00 |
$62,000.00 |
$81,000.00 |
| Net Income from Continuing Operations |
-$32.49M |
-$23.63M |
-$29.67M |
-$20.15M |
-$25.34M |
| Net cash flow from continuing operations |
-$18.53M |
-$19.29M |
-$15.84M |
-$13.28M |
-$17.06M |
| Operating Cash Flow |
-$18.53M |
-$19.29M |
-$15.84M |
-$13.28M |
-$17.06M |
| Net Cash Flow from Continuing Financing Activities |
$463.42M |
$10.05M |
$623,000.00 |
-$368,000.00 |
$218.38M |
| Proceeds from Stock Option Exercised |
$29.94M |
$10.05M |
$721,000.00 |
$209,000.00 |
$1.75M |
| Ending Cash Balance |
$135.51M |
$132.18M |
$98.90M |
$101.73M |
$119.44M |
| Net Change in Cash |
$3.32M |
$33.29M |
-$2.84M |
-$17.71M |
$17.73M |
| Beginning Cash Balance |
$132.18M |
$98.90M |
$101.73M |
$119.44M |
$101.71M |
| Free Cash Flow |
-$18.63M |
-$19.29M |
-$15.84M |
-$13.28M |
-$17.20M |
| Net Common Stock Issuance |
– |
– |
$0.00 |
-$458,000.00 |
– |
| Net Other Financing Charges |
– |
– |
-$98,000.00 |
– |
– |
No comments yet — be the first to weigh in on ELVN.